Should I Invest In Centrica Plc?

Can Centrica PLC’s (LON: CNA) total return beat the wider market?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

To me, capital growth and dividend income are equally important. Together, they provide the total return from any share investment and, as you might expect, my aim is to invest in companies that can beat the total return delivered by the wider market.

To put that aim into perspective, the FTSE 100 has provided investors with a total return of around 3% per annum since January 2008.

Quality and value

If my investments are to outperform, I need to back companies that score well on several quality indicators and buy at prices that offer decent value.

So this series aims to identify appealing FTSE 100 investment opportunities and today I’m looking at Centrica (LSE: CNA) (NASDAQOTH: CPYYY.US), the integrated gas and electricity company.

With the shares at 387p, Centrica’s market cap. is £19,930 million.

This table summarises the firm’s recent financial record:

Year to December 2008 2009 2010 2011 2012
Revenue (£m) 20,872 21,963 22,423 22,824 23,942
Net cash from operations (£m) 297 2,647 2,428 2,337 2,820
Adjusted earnings per share 21.7p 21.7p 25.2p 25.6p 27.1p
Dividend per share 12.63p 12.8p 14.3p 15.4p 16.4p

The recent steady-as-she goes interim results statement is encouraging. Centrica had a good year in 2012, thanks to the long, cold winter in Britain so, as we move into the second half of the year, there’s a tough comparator to follow. Those with long memories will recall the firm’s downstream operations struggling to turn a profit during 2011, thanks to the exceptionally mild winter conditions in Britain! Anything could happen this year, then.

To put things in perspective, the firm derives its operating profits from both upstream and downstream operations in roughly equal proportion. By customer location, around 71% of revenue comes from the UK, 24% from North America and 5% from the rest of the world.

The firm’s downstream operations supply both gas and electricity, as British Gas in Britain and as Direct Energy in the US. Upstream operations, which bear the Centrica brand, include oil and gas exploration, production and storage activities, owning and operating seven combined cycle gas turbine (CCGT) electricity-generating power stations, offshore wind generating operations, and a 20% stake in EDF Energy’s eight UK nuclear power stations.

Constant energy demand and Centrica’s steady looking financial record makes me optimistic about the company’s total-return prospects. 

Centrica’s total-return potential

Let’s examine five indicators to help judge the quality of the company’s total-return potential:

1. Dividend cover: adjusted earnings covered last year’s dividend around 1.7 times. 3/5

2. Borrowings: net debt is running at around 1.8 times the level of operating profit. 4/5          

3. Growth: revenue, earnings and cash flow have all been growing nicely. 5/5

4. Price to earnings: a forward 13 recognises earnings growth and yield expectations 3/5

5. Outlook: satisfactory recent trading and a positive outlook. 4/5

Overall, I score Centrica 19 out of 25, which encourages me to believe the firm has potential to out-pace the wider market’s total return, going forward.

Foolish Summary

This is a good set of numbers against my quality and values indicators. Admittedly, the valuation looks quite ‘well-nourished’, but a long record of rising dividends backs up the forward dividend yield of around 4.7%.

I’m considering buying Centrica along with an idea from the Motley Fool’s top value investor who has discovered what he believes is the best income generating share-play for 2013. He set’s out his three-point investing thesis in a report called “The Motley Fool’s Top Income Share For 2013”, which I recommend you download now. For a limited time, the report is free so, to download it immediately, and discover the identity of this dividend-generating star, click here.

> Kevin does not own shares in Centrica.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Investing Articles

Investing £10K into this FTSE 100 giant could bag me a second income worth £980

This Fool explains how dividend investing in the right picks could help build a second income stream, as well as…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

The Nasdaq just tanked. Here are 3 US growth stocks to consider for an ISA now

These Nasdaq stocks have a lot of potential in the long run and Edward Sheldon believes they could be worth…

Read more »

Investing Articles

Potentially 42% undervalued, is this FTSE 100 company a sleeping giant?

The FTSE 100 is full of opportunities for the patient investor, and I think I may have found one that…

Read more »

Investing Articles

AstraZeneca, a mega-cap growth stock that just got cheaper!

Our writer takes a closer look at this growth stock -- which also happens to be the largest company of…

Read more »

Investing Articles

How I’d invest £5,000 in FTSE growth stocks right now

Sumayya Mansoor explains why she’s bullish about these FTSE growth stocks, and would be willing to buy some shares.

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

ITV shares down after revenue guidance cut in first-half interim results

After releasing results this morning, the ITV share price slumped. But with several metrics looking positive, how will this effect…

Read more »

Investing Articles

This FTSE 100 stock’s down 50%, and a director just bought 8,000 shares

Directors of this blue-chip company have been snapping up a load of its shares. Should I do likewise and buy…

Read more »

Investing Articles

The BT share price is far too cheap, analysts say!

The BT share price fell on Thursday 25 July after the company's Q1 results. Dr James Fox takes a closer…

Read more »